🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess how fast pegilodecakin gets into the...
Status
Completed
Location
PPD Phase 1 Clinic
Start Date
2018-01-19
Trial ID
NCT04194892
Treatments Being Tested
To compare the efficacy of pegilodecakin in combination with pembrolizumab ...
Status
Terminated
Location
CCI - Clearview Cancer Institute
Start Date
2018-03-19
Trial ID
NCT03382899
Treatments Being Tested
To compare the efficacy of pegilodecakin in combination with FOLFOX versus ...
Status
Completed
Location
Banner MD Anderson Cancer Center
Start Date
2017-03-01
Trial ID
NCT02923921
Treatments Being Tested
This is an Expanded Access Program (EAP) available to patients who have adv...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT03554434
Treatments Being Tested
To evaluate the pharmacokinetics of different dose levels and dose formulat...
Status
Completed
Location
PPD Development
Start Date
2017-12-18
Trial ID
NCT03381547
Treatments Being Tested
To evaluate the pharmacokinetics of single and multiple doses of pegilodeca...
Status
Completed
Location
PPD Development
Start Date
2017-09-05
Trial ID
NCT03267732
Treatments Being Tested
This is a first-in-human, open-label, dose escalation study to evaluate the...
Status
Completed
Location
UCLA Medical Hematology & Oncology
Start Date
2013-11-15
Trial ID
NCT02009449
To compare the efficacy of pegilodecakin in combination with nivolumab vers...
Status
Terminated
Location
Arizona Oncology Associates, P.C.
Start Date
2018-03-22
Trial ID
NCT03382912
Treatments Being Tested